Skip to main content

Table 3 Estimated effect (EE) and effect size (ES) of early engagement in Learning Collaboratives

From: Expanding access to medications for opioid use disorder in primary care clinics: an evaluation of common implementation strategies and outcomes

  Early engagement with a prescriber vs. Early engagement without a prescriber
Q1 Q2 Q3
Reach
Number of patients with OUD
  EE (95% CI) 22.77 (−1441.20, 1486.74) 8.82 (−696.67, 714.31) −5.13 (−1468.98, 1458.72)
  ES (95% CI) 0.32 (−20.34, 20.99) 0.12 (−9.83, 10.08) −0.07 (−20.74, 20.59)
Number of patients prescribed MOUD
  EE (95% CI) 6.19 (−47.23, 59.60) 1.97 (−34.05, 38.00) −2.25 (−55.66, 51.17)
  ES (95% CI) 0.37 (−2.79, 3.53) 0.12 (−2.02, 2.25) −0.13 (−3.29, 3.03)
Percent of patients prescribed MOUDa
  EE (95% CI) −8.02 (−12.83, −3.20) 0.31 (−3.59, 4.22) 8.65 (1.39, 15.90)
  ES (95% CI) −0.22 (−0.36, −0.09) 0.01 (−0.10, 0.12) 0.24 (0.04, 0.44)
Adoption
Number of prescribers
  EE (95% CI) 0.35 (−3.99, 4.68) 1.37 (−2.41, 5.15) 2.40 (−1.93, 6.73)
  ES (95% CI) 0.08 (−0.89, 1.04) 0.31 (−0.54, 1.15) 0.54 (−0.43, 1.50)
Number of x-waivered prescribers
  EE (95% CI) 0.29 (−1.47, 2.05) 0.75 (−0.76, 2.26) 1.21 (−0.54, 2.97)
  ES (95% CI) 0.10 (−0.51, 0.71) 0.26 (−0.26, 0.79) 0.42 (−0.19, 1.03)
Number of active x-waivered prescribers
  EE (95% CI) 0.36 (−0.28, 1.00) 0.73 (0.22, 1.25) 1.10 (0.46, 1.74)
  ES (95% CI) 0.20 (−0.16, 0.55) 0.40 (0.12, 0.69) 0.61 (0.25, 0.96)
Percent of x-waivered prescribers
  EE (95% CI) −1.73 (−2.76, −0.70) −1.94 (−2.85, −1.02) −2.14 (−3.18, −1.11)
  ES (95% CI) −0.08 (−0.13, −0.03) −0.09 (−0.13, −0.05) −0.10 (−0.14 −0.05)
Implementation quality
IMAT implementation quality
  EE (95% CI) 0.33 (0.25, 0.42)
  ES (95% CI) 0.55 (0.41, 0.69)
  1. aPrimary outcome; EE and ES in bold indicated 95% CI did not cross zero